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Abstract
Indoleamine 2,3-dioxygenesae-1 (IDO-1) catalyses the initial, rate-limiting step in tryptophan metabolism, thereby
regulating tryptophan availability and the formation of downstream metabolites, including picolinic and quinolinic acid. We
found that Mycobacterium tuberculosis infection induced marked upregulation of IDO-1 expression in both human and
murine macrophages in vitro and in the lungs of mice following aerosol challenge with M. tuberculosis. The absence of IDO-1
in dendritic cells enhanced the activation of mycobacteria-specific T cells in vitro. Interestingly, IDO-1-deficiency during M.
tuberculosis infection in mice was not associated with altered mycobacteria-specific T cell responses in vivo. The bacterial
burden of infected organs, pulmonary inflammatory responses, and survival were also comparable in M. tuberculosis-
infected IDO-1 deficient and wild type animals. Tryptophan is metabolised into either picolinic acid or quinolinic acid, but
only picolinic acid inhibited the growth of M. tuberculosis in vitro. By contrast macrophages infected with pathogenic
mycobacteria, produced quinolinic, rather than picolinic acid, which did not reduce M. tuberculosis growth in vitro.
Therefore, although M. tuberculosis induces robust expression of IDO-1 and activation of tryptophan metabolism, IDO-1-
deficiency fails to impact on the immune control and the outcome of the infection in the mouse model of tuberculosis.
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Introduction
A critical requirement for controlling Mycobacterium tuberculosis
infection in humans and mice is the host’s ability to produce and
respond to IFN-c [1–4]. One well-characterized target gene of
IFN-c signalling is Indoleamine 2,3-dioxygenase-1 (IDO-1), the
first rate-limiting enzyme of tryptophan metabolism along the
kynurenine pathway, leading to the formation of tryptophan
metabolites, including quinolinic and picolinic acid.
IDO-1 activity and products of the tryptophan-kynurenine
pathway can influence immune functions through the effects of
tryptophan depletion and the generation of biologically active
tryptophan metabolites. IDO-1 activation has been shown to
restrict intracellular growth of Toxoplasma gondii, Leishmania
donovanii and Chlamydia spec by limiting tryptophan availability
[5–7]. Similarly, IDO-1 activity in antigen-presenting cells
(APCs) inhibits T cell proliferation, which can be reversed by
the addition of excess tryptophan [8]. This indicates that IDO-1
activation may represent a means of regulating local T cell
responses. Besides their effects on host immune cells, tryptophan
metabolites can directly inhibit the growth of some bacterial
pathogens in liquid cultures in vitro [9,10].
IDO-1 expression and activation of the tryptophan-kynurenine
pathway have been associated with mycobacterial infection in both
humans and mice. Elevated levels of IDO-1 mRNA expression
were detectable in sputum samples in a cohort of tuberculosis
patients [11]. In mice, infection with Mycobacterium bovis, Bacille
Calmette Guerin (BCG) lead to increased IDO-1 activity as
indicated by elevated levels of kynurenine in serum, lung and brain
[12]. In M. tuberculosis-infected mice, non-haematopoietic cells
express IDO-1 during the chronic phase of infection. IFN-c-
receptor-deficiency in these cells lead to a lack of IDO-1
expression and was associated with exuberant neutrophil recruit-
ment and increased mortality [13]. It is currently unknown if and
how IDO-1 activity directly contributes to control of mycobacte-
rial infection in the infected host. We hypothesized that IDO-1
could play a dichotomous role in the immune control of M.
tuberculosis. Local tryptophan depletion as well as production of
tryptophan metabolites might impair effective anti-mycobacterial
T cell activation, differentiation and proliferation and, thus, favour
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tryptophan metabolites have been shown to exert direct anti-
mycobacterial effects, however at relatively high concentrations
[13,51]. We addressed the role of IDO-1 in the immune control of
mycobacterial infection using human and murine macrophages as
well as mice lacking IDO-1. Our data demonstrate that IDO-1 is
one of the most highly induced genes in human macrophages
infected with M. tuberculosis. Genetic ablation of IDO-1 expression
or chemical inhibition of IDO activity did not affect intracellular
survival of M. tuberculosis in cultured macrophages nor did it
influence bacterial growth, T cell activation in vivo or survival of
infected mice. Therefore, although M. tuberculosis induces expres-
sion of IDO-1 and subsequent activation of tryptophan metabo-
lism, the lack of IDO-1 does not impact on the survival of the host
or the pathogen in a mouse model of tuberculosis infection.
Materials and Methods
Human and Animal Ethics Statement
All mouse procedures performed in this study were conducted
following the NIH guidelines for housing and care of laboratory
animals and performed in accordance with institutional regula-
tions after protocol review and approval by the University of
Sydney Animal Ethics Committee (K75/2-2006/3/4281) and the
Institutional Animal Care and Use Committee of Weill Cornell
Medical College (#0607-511A).
Ethical clearance to obtain human broncho-alveolar lavage cells
for this study was given by the Weill Cornell Medical College
Review Board (#109005117) and all participants gave written
informed consent. Experiments involving Buffy coats (obtained
from the Red Cross, Approval # 05-06NSW-04, without any
identifying information) were carried out with approval from the
Sydney South West Area Health Service Human Research Ethics
Committee (#X05-0178).
Bacteria
M. tuberculosis (strain 1254 [ATCC 51910]), was purchased from
American Type Culture Collection (ATCC). M. tuberculosis H37Rv
and Erdman were obtained from R. North (Trudeau Institute,
NY) and J.D. McKinney (EPFL, Lausanne, Switzerland), respec-
tively.
Animals
Female C57BL/6 mice at 6–10 weeks of age were purchased
from the Animal Resource Centre (Perth, Australia) and Jackson
Laboratory. IDO-1 gene deficient mice (IDO-1
2/2) [14] were
kindly provided by Prof. A. Mellor (Georgia Health Sciences
University, GA). P25 CD4
+ TCR transgenic mice (specific for
residues 240–254 of Ag85B) [15] were kindly provided by Prof. K.
Takatsu (University of Tokyo, Japan) and Prof. J. Ernst (New York
University, NY). Mice were kept in specific pathogen-free
conditions.
Bacterial Cultures
Cultures of M. tuberculosis 1254, were grown until early log phase
in Middlebrook 7H9 medium and then diluted to an optical
density (OD) at 580 nm of 0.01. Picolinic acid, quinolinic acid, L-
kynurenine, nicotinic acid, (all Sigma) or HEPES buffer (solvent
control) were added. Bacterial growth was monitored in 150 ml
aliquots in 96 well plates by OD580 nm measurement. For survival
in the presence of picolinic acid under different pH conditions,
single-cell suspensions of M. tuberculosis Erdman cultures [16] were
diluted to an OD580 nm of 0.1 and exposed to picolinic acid and
HEPES or MES as solvent controls, respectively, at 376C in 7H9
medium at pH6.6 and pH5.5 for the times indicated. Serial
dilutions of culture material were plated on Middlebrook 7H11
plates supplemented with 10% oleic acid/albumin/dextrose
catalase (OADC) and 0.5% glycerol. Plates were incubated at
376C for 3 weeks and bacterial numbers determined by
enumerating colony forming units (CFU).
Macrophage Cultures
Human broncho-alveolar lavage (BAL) cells from healthy
individuals (macrophage content .90%) were plated in antibiotic
free medium with IFN-c (100 IU/ml) overnight. Cells were
infected with M. tuberculosis 1254 for 4 h at a multiplicity of
infection (MOI) of 1 and washed to remove extracellular bacteria.
Bacterial numbers were determined by plating serial dilutions of
macrophage lysates and CFU determination. Mononuclear cells
were isolated from Buffy coats and differentiated into monocyte-
derived macrophages (MDM) for 6 days in complete medium as
previously described [17]. Macrophages were detached and plated
in 96 well plates at 1 x 10
5 cells/well in antibiotic free medium
with IFN-c (100 IU/ml) overnight, prior to mycobacterial
infection. IFN-c-activated macrophages were infected with M.
tuberculosis H37Rv or M. bovis BCG Pasteur for 4 h at an MOI of 1
(Mtb) or 5 (BCG) and intracellular bacterial survival was
monitored. Bone marrow cells from 8 to 10 week-old mice were
differentiated into macrophages, and infected with M. tuberculosis
1254 or H37Rv from early log phase cultures at an MOI of 1.
Intracellular survival was monitored as described [18].
Gene Expression Analyses
For microarrays, human BAL cells were obtained from 4
individual donors and infected with M. tuberculosis 1254 at an MOI
of 3–5. After 24 h, macrophages were lysed in Trizol (GIBCO
BRL) and total RNA was isolated. After treatment with DNase I
(Ambion) and purification (QIAGEN RNeasy), RNA (2–3 mg) was
reverse transcribed (Superscript II; GIBCO BRL) with a T7-polyT
primer and cDNA transcribed in the presence of biotinylated UTP
and CTP (Enzo). Hybridization to Affymetrix GeneChip oligo-
nucleotide arrays and scanning (Gene-Array Scanner) followed
Affymetrix, Inc. protocols. Primary image analysis of the arrays
was performed using GeneChip Microarray Analysis Suite 5.0
(Affymetrix, Santa Clara, CA) and images were scaled to an
average hybridization intensity (average difference) of 250. Data
analysis was carried out using GeneSpring 7.2 software (Silicon
Genetics, Redwood City, CA). Normalization was applied using
the distribution of all genes on each chip, i.e. all measurements on
each chip were divided by the 50
th percentile value of that chip.
Next, each gene was compared to its control by dividing its
intensity by the average intensity of that gene in the untreated
control macrophages. Data from 4 independent replicate exper-
iments were used to perform a Wilcoxon two-sample rank test for
each gene. Only genes with an Affymetrix ‘‘present call’’ in one of
the two conditions compared were included in the analysis. A gene
was considered ‘‘regulated’’ compared to control if its expression
changed across the 4 experiments with P # 0.05. Data mining was
carried out with FileMakerPro 6.
For RT-PCR and quantitative RT-PCR total RNA was
prepared from stimulated macrophages using RNAzol tri-reagent
(Sigma) and transcribed into cDNA. PCR was performed using the
gene specific primers shown in Table 1.
Western Blot
Equal amounts of hMDM lysates were separated by SDS-
PAGE and transferred onto nitrocellulose membrane. Briefly,
lysates were loaded onto 0.75-mm, 12% polyacrylamide precast
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ing non-reducing conditions. Proteins from the gels were
transferred onto nitrocellulose membranes using a Bio-Rad Mini
Transblot system for 1 h at 140 V. The membranes were blocked
with PBS/5% skim milk powder overnight at 4uC, washed and
incubated with sheep anti-human IDO-1 antibody (Chemicon
International), followed by washing and incubation with rabbit
anti-sheep IgG (Invitrogen), then donkey anti-rabbit IgG conju-
gated to HRP (Amersham, Life Science) all in PBS/1% BSA for
1 h at RT. Immunoreactive bands were detected by luminol
detection kit (Pierce, Rockford, IL) after exposure to Kodak x-ray
film using the Curix 60 X-ray developer (AGFA, Gevaert Ltd,
Nunawading, Australia).
Quantification of Tryptophan Metabolites
Human BAL cells (in 1% fetal bovine serum) were stimulated
with M. tuberculosis 1254 (MOI 3) or human IFN-c, (R&D Systems,
100 U or 500 U) for 48 h at 376C. Human monocyte-derived
macrophages were cultured for 24–72 h as described above.
Quinolinic acid and picolinic acid were determined in cell culture
supernatants using electron-capture negative-ion gas chromatog-
raphy-mass spectrometry as described previously [19].
In vitro T Cell Activation
Dendritic cells were generated from bone marrow as previously
described [20]. DCs were cultured for 2 h with Ag85 peptide P25
before being overlaid with CFSE labelled CD4
+ T cells from P25-
specific T cell receptor transgenic mice [15]. T cell proliferation
was determined by flow cytometry using a FACS LSRII (BD, San
Jose, CA).
Mouse Infections
Female C57BL/6 and IDO-1
2/2 mice were infected with
,100 cfu M. tuberculosis H37Rv by aerosol in a Middlebrook
airborne infection apparatus (Glas-Col, Terre Haute, IN).
Mycobacterial loads in infected organs were assessed by culture
of serial dilutions of organ homogenates on 7H11 agar (Difco) at
37uC for 3 weeks.
To assess lymphocyte responses to mycobacterial antigens,
single cell suspensions of lung and mediastinal lymph nodes were
prepared as previously described [20,21]. 2610
5 cells per well
were incubated with culture filtrate protein (CFP) (kindly provided
by Dr J. Belisle under the National Institute of Health TB research
material and vaccine-testing contract NIH, NIAID Contract No.
HHSN266200400091C) or at 1610
5 cells/well in ELISPOT
plates overnight. The number of cells producing IFN-c was
determined as described previously [21].
To determine lung inflammation the percentage of the, formalin
fixed, haematoxylin and eosin stained lung with inflammatory cell
infiltration from WT and IDO-1
2/2 mice was calculated using
Image-Pro Plus software (Media Cybernetics, Silver Spring, USA)
and Adobe Photoshop and is represented as the percentage of the
whole lung tissue involved after subtracting the background
cellularity in normal lung.
Immunohistochemistry
Formalin-fixed paraffin-embedded sections were de-waxed in
xylene, rehydrated through an ethanol gradient and washed in
Tris-buffered saline (TBS) before blocking of endogenous perox-
idase with 3% H2O2 in methanol. Sections were microwaved in
0.01 M citrate buffer (pH 6.0), for antigen retrieval, washed again
in TBS then blocked with 20% normal horse serum for 30 min at
RT. Sections were stained with polyclonal rabbit-anti-IDO-1
antibody (Enzo Life Sciences, USA) or rabbit control IgG (R&D
Systems, USA) in a humidified chamber overnight at 4uC.
Sections were washed in TBS before applying a HRP-conjugated
horse-anti-rabbit IgG (Vector Laboratories, USA) for 30 min at
RT, following which sections were stained with DAB peroxidase
substrate (Vector Laboratories, USA) and counterstained with
haematoxylin.
Statistical Analysis
Statistical analysis was conducted by analysis of variance
(Statview SAS Institute, NC). Fishers’ Protected Least Significant
Difference analysis of variance post-hoc test was used for pair-wise
comparison of data from multiple groups. Survival was calculated
on a Kaplan-Meier nonparametric survival plot and significance
was assessed by the Logrank-Mantel-Cox test. Differences with
p,0.05 were considered significant.
Results
Mycobacteria-induced IDO-1 Expression in Macrophages
Human broncho-alveolar lavage (BAL) cells from four healthy
individuals were infected with M. tuberculosis for 24 h and gene
expression analyses were performed using microarrays. Compared
to uninfected control cells, one of the genes most prominently
upregulated in response to M. tuberculosis infection was IDO-1
(46.05 fold) (Fig. 1A). Furthermore, expression of two other
enzymes in the kynurenine pathway, Kynurenine 3-monooxygen-
ase and L-Kynurenine hydrolase, was enhanced in infected
compared to uninfected cells at this time point (1.76 and 2.21
fold respectively) (Fig. 1A). IDO-1 mRNA and protein expression
were also increased in IFN-c-stimulated human monocyte-derived
macrophages (hMDM) in response to infection with M. bovis BCG
(Fig. S1A and S1B). Similarly, we observed an increase in IDO-
1 mRNA expression in murine bone marrow-derived macrophag-
es (mBMDM) upon infection with M. tuberculosis. IFN-c stimulation
in conjunction with M. tuberculosis further enhanced IDO-1 mRNA
expression (Fig. 1B).
The Tryptophan-kynurenine Pathway is Active in
M. tuberculosis-infected Human Macrophages
We next investigated if the tryptophan-kynurenine pathway is
activated in M. tuberculosis-infected macrophages, by determining
the concentrations of the tryptophan metabolites picolinic and
quinolinic acid released from infected human alveolar macro-
phages and monocyte-derived macrophages (MDM). Upon
infection of human alveolar macrophages with M. tuberculosis or
stimulation with IFN-c, the quinolinic acid concentration in the
supernatant was increased (Fig. 2A). The simultaneous application
of both M. tuberculosis and IFN-c did not induce synergistic effects
(Fig. 2A). Similarly, quinolinic acid concentrations were increased
Table 1. Gene specific primers used in this study.
Gene Forward 59-39 Reverse
hIDO-1 GGCAAAGGTCATGGAGATGT TCCAGTTTGCCAAGACACAG
hGAPDH CATGTTCGTCATGGGTGTGAA ATGGACTGTGGTCATGAGTCCTT
mIDO-1 TTATGCAGACTGTGTCCTGGCAAA TTTCCAGCCAGACAGATATATGCG
mb2m TGACCGGCTTGTATGCTATC CAGTGTGAGCCAGGATATAG
IDO-2 TGCCTGATGGCCTATAACCAGTGT TGCAGGATGTGAACCTCTAACGCT
TDO ATGAGTGGGTGCCCGTTTG GGCTCTGTTTACACCAGTTTGAG
doi:10.1371/journal.pone.0037314.t001
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unstimulated controls (Fig. 2B). Subsequent infection of IFN-c-
primed MDM with mycobacteria did not further enhance the
concentration of quinolinic acid in the supernatant over a period
of three days following the infection (Fig. 2B). There was a
considerable difference in the amounts of quinolinic acid produced
by alveolar macrophages compared to MDM. This is in
concordance with a previous observation showing differences in
the production of quinolinic acid by different macrophage types
(MDM compared to microglia), despite comparable levels of IDO-
1 mRNA expression [22]. In contrast to quinolinic acid, no
increased concentrations of picolinic acid were detected upon
stimulation of MDM (Fig 2C).
IDO-1-deficiency in Dendritic Cells Enhances Proliferation
of Mycobacteria-specific CD4
+ T Cells in vitro
Along with modulation of macrophage functions, IDO-1
activity and tryptophan depletion have also been shown to
suppress T cell proliferation [23]. We examined this in the context
of a mycobacterial infection measuring the capacity of DCs from
WT and IDO-1
2/2 mice to induce the proliferation of P25-
transgenic T cells, which recognise P25, a peptide from the
mycobacterial secreted protein Ag85 [15]. In the absence of IDO-
1 expression by DCs, T cells commenced proliferating earlier
(Fig. 3A, 3D) and more cells had entered division by day 5 (Fig. 3B,
3E). Treatment of WT DCs with the IDO inhibitor 1-Methyl-DL-
tryptophan [24] had a similar effect, with more cells entering
division and undergoing more rounds of division than T cells in
cultures with untreated DCs (Fig. 3C, F). Our findings support the
hypothesis that IDO-1 activity in APCs can regulate T cell
proliferation in response to mycobacterial antigens in vitro.
Normal Cellular Influx and Generation of Antigen-specific
T Cells in the Absence of IDO-1 During M. tuberculosis
Infection in vivo
Given that IDO-1 deficiency enhanced mycobacteria-specific T
cell proliferation in vitro we examined the influence of IDO-1 on
the generation of an antigen-specific T cell response following
infection with M. tuberculosis in vivo. WT and IDO-1
2/2 mice were
infected with M. tuberculosis via aerosol and the influx and
activation status of CD4
+ and CD8
+ T cells in infected lungs
were assessed over time. Similar total numbers of activated
(CD44
hi/CD62
lo) CD4
+ and CD8
+ T cells were found in the lungs
and lymph nodes of infected WT and IDO-1
2/2 mice (Fig. 4A–
D). Furthermore, the numbers of antigen specific T cells that
produced IFN-c in response to secreted M. tuberculosis antigens
were equivalent in WT and IDO-1
2/2 mice throughout the
course of infection (Fig. 4E). Thus, IDO-1-deficiency did not affect
the influx or activation of M. tuberculosis-specific T cells in vivo.
IDO-1 is not Essential to Control M. tuberculosis Growth
in the Host or Enhance Survival of Infected Mice
We further investigated if IDO-1 activity in macrophages
modulated intracellular survival of M. tuberculosis. To this end, we
infected WT and IDO-1
2/2 murine macrophages with M.
tuberculosis and monitored intracellular bacterial numbers over
time. Similar bacterial numbers were observed in IDO-1
2/2 and
WT macrophages (Fig. 5A). Furthermore, when infecting human
or murine macrophages with M. tuberculosis in the presence or
absence of the IDO inhibitor 1-Methyl-DL-tryptophan [24], no
differences in intracellular bacterial numbers were detected
(Fig. 5B and Fig. S2).
Although the absence of IDO-1 did not influence the
development of an antigen-specific T cell response in vivo,w e
found that IDO-1 is strongly expressed within the lungs of M.
tuberculosis-infected mice (Fig. 6A–C). Thus, we examined the
requirement for IDO-1 to control bacterial growth, inflammation,
and survival of mice infected with M. tuberculosis. Bacterial burden
in WT and IDO-1
2/2 mice in lungs, spleen, and livers were
similar during the course of infection (Fig. 6D and Fig. S3). The
extent and quality of the inflammatory infiltrate in lungs of IDO-1
deficient mice were comparable to WT mice (Fig. 6E) and
equivalent survival post infection was observed in both WT and
IDO-1
2/2 mice (Fig. 6F). These results demonstrate that IDO-1
was not essential for the immune control of M. tuberculosis in vivo or
the survival of infected mice.
Figure 1. M. tuberculosis infection increases IDO-1 expression in human and murine macrophages. (A) Microarray results of BAL cells
(.90% macrophages) infected with M. tuberculosis (MOI 3–5) for 24 h compared to uninfected cells. Increased mRNA expression levels for
Indoleamine 2,3-dioxygenase (IDO-1), Kynurenine 3-monooxygenase (KYN-OX), and L-Kynurenine hydrolase (KYN-HYD) are depicted as fold induction
upon M. tuberculosis infection compared to uninfected control cells. Data are means +/2 standard error of comparisons of microarray data obtained
from four different individuals. (B) Murine bone marrow-derived macrophages were left untreated (1), infected with M. tuberculosis (MOI 5) (2) and
stimulated with IFN-c (100 U/ml) (3). Co-stimulation with both M. tuberculosis and IFN-c was either performed simultaneously (4) or cells were pre-
treated with IFN-c for 24 h and then infected with M. tuberculosis for 24 h (5) before RNA isolation. IDO-1 mRNA expression and beta-2-microglobulin
(control) were detected at 4, 24, and 48 h by RT-PCR. (6) H2O. Data are representative of two independent experiments.
doi:10.1371/journal.pone.0037314.g001
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vitro
M. tuberculosis infection of macrophages led to IDO-1 expression
and production of quinolinic acid, but not picolinic acid.
Therefore, the direct effect of tryptophan metabolites on M.
tuberculosis growth in liquid culture was examined. Neither
quinolinic acid nor kynurenine, an upstream tryptophan metab-
olite, inhibited growth of M. tuberculosis (Fig. S4). Whereas picolinic
Figure 2. Mycobacteria and IFN-c activate tryptophan-kynurenine metabolism in macrophages. (A) Human bronco-alveolar lavage cells
were infected with M. tuberculosis (MOI 3) and stimulated with IFN-c (100 and 500 U/ml) for 48 h. The concentration of quinolinic acid in cell culture
supernatants was detected by electron-capture negative-ion gas chromatography-mass spectrometry. Data points are means +/2 SD of triplicate
wells representative of two independently performed experiments. Unpaired t test was used to compare raw data of three independent wells.
(***P=0.0003, **P,0.01, all other comparisons showed no significant difference) (B) Quinolinic and (C) picolinic acid concentrations in cell culture
supernatants of human monocyte-derived macrophages stimulated overnight with IFN-c (100 U/ml) before infection for 24, 48, and 72 h with M.
bovis BCG (MOI 5). Data points represent measurements obtained for cells from two individuals.
doi:10.1371/journal.pone.0037314.g002
Figure 3. IDO-1 regulates CD4 T cell responses to mycobacterial antigen in vitro. Bone marrow-derived DCs were cultured for 4 days in
vitro before stimulation for 2 h with Ag85 peptide P25. DCs were overlaid with CFSE labelled CD4
+ T cells from P25-specific T cell receptor transgenic
mice. Proliferation of T cells was determined by flow cytometry. DCs from WT and IDO-1
2/2 mice were compared in their ability to induce
proliferation of P25-specific T cells after 2 days (A, D) and 5 days (B, E). WT DCs were treated with 1 Methyl-DL-tryptophan before stimulation with P25
peptide. P25-specific T cell proliferation was determined after 5 days (C, F). (A-C) Fluorescence intensities of representative FACS plots are depicted.
Grey- IDO-1
2/2/1-Methyl-DL-tryptophan, Black – WT/untreated control. The percentages of cells per division were calculated (D-F). Data represent
the mean +/2 SD of triplicate cultures from one of three representative experiments. The differences between groups were analysed by analysis of
variance, *P,0.001.
doi:10.1371/journal.pone.0037314.g003
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macrophages (Fig. 2C), inhibited M. tuberculosis growth in a dose
dependent fashion at high mM concentrations (Fig. 7A). However,
tryptophan metabolite concentrations in biological samples, such
as serum and cerebrospinal fluid in humans and mice, are in the
low mM range, reaching up to 100 mM in severe malaria [25–27].
We determined if lower concentrations of picolinic acid could act
synergistically with known antimicrobial effector mechanisms in
macrophages, such as acidification of the phagosome. At pH 6.6,
picolinic acid was bacteriostatic, whereas at pH 5.5 picolinic acid
exhibited bactericidal activity (Fig. 7B, 7C). Furthermore, while at
pH 6.6 100 mM picolinic acid did not impair M. tuberculosis growth
after 8 days of exposure, the same concentration of picolinic acid
at pH 5.5 had bactericidal activity resulting in a 78-fold decrease
of viable M. tuberculosis in the medium. These findings suggest that
tryptophan metabolism in infected macrophages bears the
potential to generate anti-mycobacterial compounds if directed
towards the production of picolinic acid in an acidified compart-
ment.
Figure 4. Normal cellular influx and the generation of antigen-specific T cells in the absence of IDO-1 in vivo. WT and IDO-1
2/2 mice
were infected with M. tuberculosis (100 CFU). Single cell suspensions were prepared from infected lungs and analyzed by flow cytometry for (A) CD4+,
(B) CD8+ cells, and the percentages of these cells with an activated CD44hi/CD62lo phenotype ((C) CD4+, (D) CD8+). (E) Numbers of IFN-c producing
cells determined by ELISpot for lung cells cultured at 1610
5 cells/well with M. tuberculosis CFP overnight. Data represent the mean +/2 SD of 5 mice
from one representative of two experiments.
doi:10.1371/journal.pone.0037314.g004
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of WT and IDO-1
2/2 mice were infected with M. tuberculosis (MOI 1) in the presence of IFN-c (100 U/ml). Intracellular bacterial numbers were
determined at the indicated time points. Data points are means +/2 SD of triplicate wells of one representative of 3 independent experiments. (B)
Human BAL cells were stimulated with 100 U/ml IFN-c and infected with M. tuberculosis (MOI 1) in the presence or absence of 1-Methyl-DL-
Tryptophan (250 mM). Bacterial counts in cell lysates were determined at the times indicated. Data points are means +/2 SD of triplicate wells of one
representative of 6 independent experiments.
doi:10.1371/journal.pone.0037314.g005
Figure 6. IDO-1 is dispensable for the control of M. tuberculosis infection in vivo. WT and IDO-1
2/2 mice were infected with M. tuberculosis
(100 CFU). IDO-1 expression in the lungs of uninfected WT mice (A), and WT (B) and IDO-1
2/2 (C) mice at 28 days post infection. Lungs from
uninfected IDO-1
2/2 mice showed no IDO-1-positive cells (data not shown). IDO-1-expression in lungs of WT mice was primarily associated with
inflammatory lesions within large monocytic cells (B), while IDO-1
2/2 mice show no specific staining (C). One representative section from 1 of 5 mice
per group. Bacterial loads (D) in infected lungs were determined at the time points indicated. Data represent the means +/2 SD of 5 mice per group
from one of two independent experiments. Lung inflammation (E) as percentage of the lung area with inflammatory cell infiltration from WT and IDO-
1
2/2 mice after subtracting the background cellularity in normal lung. To assess survival (F), infected mice were monitored daily and euthanized
when showing signs of ill health. Data represent the time to euthanasia of 6 mice per group.
doi:10.1371/journal.pone.0037314.g006
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The roles of IDO-1 and tryptophan metabolism as regulatory
components of the immune system have gained much attention in
recent years. Here we demonstrate that M. tuberculosis infection
upregulated IDO-1 expression in both human and murine
macrophages in vitro and in inflammatory foci and surrounding
tissue in lungs of M. tuberculosis-infected mice (Fig. 1, S1, 6A–C).
IDO-1 expression in infected mouse lungs has been reported [13],
and elevated IDO-1 expression has recently been correlated with
the expression of other inflammatory markers, including C-
reactive protein and poor prognosis of tuberculosis patients [28].
With our study we therefore aimed to address the functions of
IDO-1 during M. tuberculosis infection.
Tryptophan metabolism has been extensively studied as a
means of regulating T cell functions in settings as diverse as tumor-
induced immune escape, peripheral tolerance and inflammation
during infection [29–31]. Enhanced IDO-1 activity during
bacterial infection might limit tryptophan availability to T cells
and thereby regulate T cell proliferation [32]. Our in vitro studies
indeed showed that IDO-1 activity in APCs inhibited mycobac-
terial antigen-specific T cell proliferation. Of note, recent studies
by Li et al. suggest that pleurisy fluid from tuberculosis patients
contains inhibitory components that interfere with T cell responses
and that this can be partially blocked with the IDO-inhibitor, 1-
Methyl-DL-tryptophan [33,34]. Together these observations
strongly suggested a role for IDO-1 activity in inhibiting M.
tuberculosis-specific adaptive immune responses and, thereby,
potentially aiding the persistence of this pathogen within the
infected host. However, our data demonstrate that IDO-1-
deficiency in vivo did not increase the number of IFN-c-
mycobacteria-specific T cells nor did it alter the numbers of
activated T cells in the lungs and lymph nodes of M. tuberculosis-
infected mice. Furthermore, IDO-1
2/2 mice did not show altered
inflammatory responses as demonstrated by the similar numbers,
size and composition of lesions in infected lungs. Increased liver
inflammation in IDO-1
2/2 mice infected with Rhodococcus equi [35]
has been reported, suggesting that the involvement of IDO-1 in
modulating inflammation in infected organs my be dependent
upon the infecting pathogen.
IDO-1 activity has also been implicated in modulating Th1 and
Th17 responses during infection with Candida albicans and the
balance between Th17 and regulatory T cell responses in HIV
disease [36,37]. A recent study suggested the presence of an
immune-regulatory loop mediated by IFN-c-induced IDO-1
expression in non-hematopoietic cells that controlled IL-17
responses and neutrophil influx into infected lungs, which was
correlated to the survival of mice during M. tuberculosis infection
[13]. Pathogenic neutrophilia in tuberculosis has further been
suggested to be associated with a failed Th1 response [38]. We
have previously shown that Th17 cells can confer some protection
to M. tuberculosis infection in mice in the absence of IFN-c
producing Th1 cells, and this is accompanied by increased
inflammation and damaging pathology [39]. The role of
regulatory T cells (Tregs) in pulmonary tuberculosis is not fully
understood but functions for Tregs in controlling bacterial burden
in the lung as well as the frequency of IFN-c producing cells have
been reported [40,41,42]. If Th17/IL-17 or Treg numbers and
functions during M. tuberculosis infection had been markedly altered
by the deficiency in IDO-1, we would have expected this to lead to
altered T cell activation, affect lung inflammation and alter the
bacterial burden in infected organs. As none of these phenotypes
were observed in IDO-12/2 mice during M. tuberculosis infection,
this suggests that any modulation of Th17 or Treg responses that
occurred in the absence of IDO-1 did not significantly diminish
the capacity of IDO-1
2/2 mice to control the disease.
Our in vitro data clearly demonstrate that DCs from IDO-1
2/2
mice, or DCs treated with 1-Methyl-DL-tryptophan, facilitated
more rapid T cell proliferation in response to a mycobacterial
antigen, in concordance with previous reports describing IDO-1-
mediated inhibition of T cell proliferation in vitro [8,43]. In
contrast, we observed no modification of anti-mycobacterial
responses in vivo. The different results observed in in vitro and in
vivo models might reflect the different microenvironments of
isolated cell culture systems versus complex organs as well as
different immunological requirements to control acute versus
chronic T cell mediated immune responses. Furthermore,
compensatory mechanisms may mask the impact of IDO-1
activity on maintaining effective T cell mediated immunity against
M. tuberculosis in vivo. There are two other tryptophan-metabolising
Figure 7. Inhibition of mycobacterial growth in vitro by picolinic acid. (A) M. tuberculosis was grown in 7H9 liquid medium in the presence
of picolinic acid (100 - 1000 mM). Optical density of cultures was measured. Data are the mean +/2 SD of four independent wells per condition and
are representative of 2–4 independent experiments. M. tuberculosis CFU were determined upon exposure to picolinic acid (0.1 and 1 mM; HEPES and
MES as buffer controls) in 7H9 liquid medium at pH 6.6 (B) and 5.5 (C). Data represent means +/2 SD of triplicate wells. Similar pH-dependent effects
of picolinic acid on M. tuberculosis survival were observed in three independent experiments.
doi:10.1371/journal.pone.0037314.g007
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drive the kynurenine pathway in the absence of IDO-1, but their
role in immunity to infection is not well understood. TDO activity
is mainly found in the liver, while IDO-2 is expressed in the
kidney, liver, epididymis and testis, but not the lung [44,45]. We
could not detect IDO-2 expression in the lungs of uninfected
C57BL/6 wild type and IDO-1
2/2 mice or during M. tuberculosis
infection in C57BL/6 mice (data not shown). We further found
that TDO was only expressed at very low levels in mouse lungs
and expression was not upregulated by M. tuberculosis infection
(data not shown), suggesting that neither TDO nor IDO-2
contribute significantly to the control of M. tuberculosis infection
in the lung. Tissue expression of both IDO-2 and TDO has
previously been shown to be independent of IFN-c. IDO-2
remained unchanged during Plasmodium berghei ANKA infection
[46] and TDO activity has also not been associated with immune-
related tryptophan metabolism [47]. Taken together, these
observations make it seem unlikely that either enzyme compen-
sates for the absence of IDO-1 activity during M. tuberculosis
infection.
For some pathogens tryptophan availability within the infected
host might be a limiting factor rendering them susceptible to
tryptophan depletion by IDO-1 activity [32]. A trpD mutant M.
tuberculosis strain has been described to be auxotroph for
tryptophan [48] and it is possible that M. tuberculosis can synthesize
tryptophan within the infected host. When we examined the anti-
microbial effects of individual tryptophan metabolites our data
demonstrated that quinolinic acid and L-kynurenine did not affect
growth of M. tuberculosis, whereas picolinic acid strongly inhibited
the growth of several mycobacterial species, but had minimal
impact on gram-positive and no effect on gram-negative bacteria
(Fig. 7 and data not shown).
Picolinic acid is an effective activator of macrophages [49] and
decreased intracellular replication of M. avium in murine macro-
phages [50]. While the underlying mechanism is unclear, iron
availability [51], interference with phago-lysosme interactions and
induction of host cell apoptosis [50,52] have been suggested.
Elevated levels of picolinic acid have been associated with cerebral
malaria in patients [25] and were detected in a mouse model of
malaria infection [53]. The picolinic acid concentrations required
for growth inhibition of M. tuberculosis in vitro, however, are at least
10–100 times higher that those observed in serum, cerebrospinal
fluid or infected macrophage cell cultures [25–27] (Fig. 2).
However, our data show that picolinic acid and an acidified
environment could provide an efficient combination of anti-
mycobacterial effector mechanisms. Yet, this would require the
presence of both in the same compartment. As we could not detect
picolinic acid in the supernatants of macrophage cultures upon
mycobacterial infection or IFN-c activation (Fig. 2C), the absence
of this potent anti-microbial agent from activated macrophages
might render this host cell an attractive niche for intracellular
pathogens like M. tuberculosis.
It is clear from the growing literature surrounding the many
functions of IDO-1 that our understanding of the impact of
tryptophan metabolism on immune regulation is far from
complete. The activation of tryptophan metabolism appears to
be part of the anti-microbial repertoire against some but not all
pathogenic bacteria. Growing evidence also indicates that IDO-1
activation and tryptophan metabolism in macrophages within the
central nervous system is involved in AIDS-related dementia and
other inflammatory brain conditions [45,54]. Inhibition of IDO-1
activity is thus an attractive therapeutic strategy in treating HIV-
associated neurological disorders. In light of the high prevalence of
patients infected with both HIV and M. tuberculosis our findings
indicate that therapeutic targeting of IDO-1 should not increase
the risk of exacerbating tuberculosis in HIV patients.
In conclusion, we demonstrate that despite a robust increase in
IDO-1 expression, activation of tryptophan metabolism in infected
macrophages and a role for DC-derived IDO-1 in regulating T
cell responses in vitro, immune control of M. tuberculosis in
macrophages occurs independently of IDO-1 and IDO-1 is
redundant for regulating control of M. tuberculosis infection in a
mouse model of tuberculosis.
Supporting Information
Figure S1 Induction of IDO-1 expression by M. bovis
BCG in human monocyte-derived macrophages. Human
monocyte-derived macrophages were stimulated with 100 U/ml
IFN-c and infected with M. bovis BCG (MOI 5). (A) IDO-1 mRNA
expression was determined by qRT-PCR at 24 h post infection.
Data points represent mean +/2 SD of IDO-1 mRNA expression
compared to uninfected control PBMC from 9 individuals. (B)
IDO-1 protein expression in cells of two individuals, stimulated for
24–72 h as described above, was determined by Western Blot.
(TIF)
Figure S2 1-Methly-DL-tryptophan does not affect the
intracellular survival of M. tuberculosis in murine bone
marrow-derived macrophages. Bone marrow-derived mac-
rophages of C57BL/6 mice were stimulated with IFN-c (100 U/
ml) were infected with M. tuberculosis (MOI 1) in the presence or
absence of 1-Methyl-DL-tryptophan (250 mM). Intracellular
bacterial numbers were determined at the indicated time points.
Data points are means +/2 SD of triplicate wells of one
representative of three independent experiments.
(TIFF)
Figure S3 Bacterial burden in spleens and livers of WT
and IDO-1
2/2 mice infected with M. tuberculosis. Mice
were infected M. tuberculosis (100 CFU) and bacterial loads in
infected spleens (A) and livers (B) were determined over time. Data
represent mean +/2 SD of 5 mice per group from one of two
independent experiments.
(TIFF)
Figure S4 Growth of M. tuberculosis in the presence of
tryptophan metabolites. M. tuberculosis was grown in 7H9
liquid medium in the presence of picolinic acid and L-kynurenine
and quinolinic acid (1 mM). Optical density of the cultures was
measured at 580 nm. Data are means +/2 SD of four
independent wells per condition and are representative of 2–4
independent experiments.
(TIFF)
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